What's new

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Feb 20, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-methyl-2-thienyl)methyl]-2...

Next Article

Revisiting the kinetics enhancement strategies of Si anodes through deconstructi...

Related Posts

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 16, 2025  0